Growth Metrics

Biocryst Pharmaceuticals (BCRX) FCF Margin: 2009-2014

Historic FCF Margin for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to -284.08%.

  • Biocryst Pharmaceuticals' FCF Margin rose 15013.00% to -116.52% in Q3 2015 from the same period last year, while for Sep 2015 it was -29.57%, marking a year-over-year increase of 12645.00%. This contributed to the annual value of -284.08% for FY2014, which is 13082.00% down from last year.
  • Biocryst Pharmaceuticals' FCF Margin amounted to -284.08% in FY2014, which was down 85.37% from -153.25% recorded in FY2013.
  • Biocryst Pharmaceuticals' 5-year FCF Margin high stood at -46.30% for FY2010, and its period low was -284.08% during FY2014.
  • In the last 3 years, Biocryst Pharmaceuticals' FCF Margin had a median value of -153.25% in 2013 and averaged -193.33%.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' FCF Margin spiked by 2,180bps in 2012, and later plummeted by 13,082bps in 2014.
  • Yearly analysis of 5 years shows Biocryst Pharmaceuticals' FCF Margin stood at -46.30% in 2010, then crashed by 11,817bps to -164.47% in 2011, then spiked by 2,180bps to -142.66% in 2012, then tumbled by 1,059bps to -153.25% in 2013, then tumbled by 13,082bps to -284.08% in 2014.